MedPath

Early Prediction of Hypocalcaemia Following Thyroid Surgery

Not Applicable
Completed
Conditions
Hypocalcemia
Interventions
Other: no dosage of iPTH
Other: iPTH
Registration Number
NCT02853721
Lead Sponsor
University of Cagliari
Brief Summary

150 patients divided into two groups.The experimental group was submitted at the assay of iPTH six hours after surgery whilst the control group was submitted to a daily assay of serum calcium and phosphorus.

Detailed Description

Purpose: The aim of this randomized controlled trial was to validate the results of a previous prospective cohort study conducted in the same surgical unit regarding the use of concomitant intact parathyroid hormone (iPTH) and serum calcium measurement in predicting hypocalcemia after total thyroidectomy.

Methods: From January 2014 to January 2015, 150 patients underwent total thyroidectomy in our department and were divided into two groups. The experimental group was submitted at the assay of iPTH six hours after surgery whilst the control group was submitted to a daily assay of serum calcium and phosphorus. Sensitivity and specificity of different serum measurements have been calculated using the Receiver-operator characteristics (ROC) curve.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Be submitted to total thyroidectomy during the study period
  • Have signed the informed consent
Exclusion Criteria
  • Lack of inclusion criteria
  • Lobectomy with isthmusectomy or partial or subtotal thyroidectomy
  • Completion thyroidectomy
  • Concomitant hyperparathyroidism was present
  • Concomitant treatment with oral calcium and/or vitamin D prior to surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupno dosage of iPTHno dosage of iPTH
Experimental groupiPTHiPTH at 6 hours after surgery
Primary Outcome Measures
NameTimeMethod
Sensibility and specificity of iPTH and serum calcium measurement1 month

Sensitivity and specificity of serum measurement using the Receiver-operator characteristics (ROC) curve

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath